Share

OD risk with kids' HIV med

Doctors need to be careful when using the anti-HIV drug Kaletra in children, says an Abbott Laboratories letter posted on the US Food and Drug Administration's Web site.

The drug maker wrote the letter after the accidental overdose death of an infant born with HIV, who died nine days after receiving a 6.5 millilitre dose of Kaletra, the Associated Press reported.

In the letter, Abbott reminds doctors that children should receive less than a 5 millilitre dose of Kaletra oral solution.

"Special attention must be paid to accurate calculation of the dose, transcription of the medication order, dispensing information and dosing instructions to minimise the risk of medication," the letter states.

Kaletra prevents reproduction of HIV, the virus that causes Aids. – (HealthDayNews)

Read more:
HIV/Aids Centre

August 2007

We live in a world where facts and fiction get blurred
Who we choose to trust can have a profound impact on our lives. Join thousands of devoted South Africans who look to News24 to bring them news they can trust every day. As we celebrate 25 years, become a News24 subscriber as we strive to keep you informed, inspired and empowered.
Join News24 today
heading
description
username
Show Comments ()
Editorial feedback and complaints

Contact the public editor with feedback for our journalists, complaints, queries or suggestions about articles on News24.

LEARN MORE